Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Systematic assessment of commercially available low-input miRNA library preparation kits.

Heinicke F, Zhong X, Zucknick M, Breidenbach J, Sundaram AYM, T Flåm S, Leithaug M, Dalland M, Farmer A, Henderson JM, Hussong MA, Moll P, Nguyen L, McNulty A, Shaffer JM, Shore S, Yip HK, Vitkovska J, Rayner S, Lie BA, Gilfillan GD.

RNA Biol. 2020 Jan;17(1):75-86. doi: 10.1080/15476286.2019.1667741. Epub 2019 Sep 27.

2.

Multicenter Evaluation of Circulating Plasma MicroRNA Extraction Technologies for the Development of Clinically Feasible Reverse Transcription Quantitative PCR and Next-Generation Sequencing Analytical Work Flows.

Kloten V, Neumann MHD, Di Pasquale F, Sprenger-Haussels M, Shaffer JM, Schlumpberger M, Herdean A, Betsou F, Ammerlaan W, Af Hällström T, Serkkola E, Forsman T, Lianidou E, Sjöback R, Kubista M, Bender S, Lampignano R, Krahn T, Schlange T; CANCER-ID consortium.

Clin Chem. 2019 Sep;65(9):1132-1140. doi: 10.1373/clinchem.2019.303271. Epub 2019 Jun 24.

PMID:
31235535
3.

Multisite, multivendor validation of the accuracy and reproducibility of proton-density fat-fraction quantification at 1.5T and 3T using a fat-water phantom.

Hernando D, Sharma SD, Aliyari Ghasabeh M, Alvis BD, Arora SS, Hamilton G, Pan L, Shaffer JM, Sofue K, Szeverenyi NM, Welch EB, Yuan Q, Bashir MR, Kamel IR, Rice MJ, Sirlin CB, Yokoo T, Reeder SB.

Magn Reson Med. 2017 Apr;77(4):1516-1524. doi: 10.1002/mrm.26228. Epub 2016 Apr 15.

4.

Comprehensive microRNA profiling in acetaminophen toxicity identifies novel circulating biomarkers for human liver and kidney injury.

Vliegenthart AD, Shaffer JM, Clarke JI, Peeters LE, Caporali A, Bateman DN, Wood DM, Dargan PI, Craig DG, Moore JK, Thompson AI, Henderson NC, Webb DJ, Sharkey J, Antoine DJ, Park BK, Bailey MA, Lader E, Simpson KJ, Dear JW.

Sci Rep. 2015 Oct 22;5:15501. doi: 10.1038/srep15501.

5.

Characterization of RNA from Exosomes and Other Extracellular Vesicles Isolated by a Novel Spin Column-Based Method.

Enderle D, Spiel A, Coticchia CM, Berghoff E, Mueller R, Schlumpberger M, Sprenger-Haussels M, Shaffer JM, Lader E, Skog J, Noerholm M.

PLoS One. 2015 Aug 28;10(8):e0136133. doi: 10.1371/journal.pone.0136133. eCollection 2015.

6.

Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study.

Mestdagh P, Hartmann N, Baeriswyl L, Andreasen D, Bernard N, Chen C, Cheo D, D'Andrade P, DeMayo M, Dennis L, Derveaux S, Feng Y, Fulmer-Smentek S, Gerstmayer B, Gouffon J, Grimley C, Lader E, Lee KY, Luo S, Mouritzen P, Narayanan A, Patel S, Peiffer S, Rüberg S, Schroth G, Schuster D, Shaffer JM, Shelton EJ, Silveria S, Ulmanella U, Veeramachaneni V, Staedtler F, Peters T, Guettouche T, Wong L, Vandesompele J.

Nat Methods. 2014 Aug;11(8):809-15. doi: 10.1038/nmeth.3014. Epub 2014 Jun 29. Erratum in: Nat Methods. 2014 Sep;11(9):971.

PMID:
24973947
7.

Alternative RISC assembly: binding and repression of microRNA-mRNA duplexes by human Ago proteins.

Janas MM, Wang B, Harris AS, Aguiar M, Shaffer JM, Subrahmanyam YV, Behlke MA, Wucherpfennig KW, Gygi SP, Gagnon E, Novina CD.

RNA. 2012 Nov;18(11):2041-55. doi: 10.1261/rna.035675.112. Epub 2012 Sep 27. Erratum in: RNA. 2012 Dec;18(12):2345.

8.

Reduced expression of ribosomal proteins relieves microRNA-mediated repression.

Janas MM, Wang E, Love T, Harris AS, Stevenson K, Semmelmann K, Shaffer JM, Chen PH, Doench JG, Yerramilli SV, Neuberg DS, Iliopoulos D, Housman DE, Burge CB, Novina CD.

Mol Cell. 2012 Apr 27;46(2):171-86. doi: 10.1016/j.molcel.2012.04.008.

9.

Assessment of pulmonary artery stiffness using velocity-encoding magnetic resonance imaging: evaluation of techniques.

Ibrahim el-SH, Shaffer JM, White RD.

Magn Reson Imaging. 2011 Sep;29(7):966-74. doi: 10.1016/j.mri.2011.04.012. Epub 2011 Jun 8.

PMID:
21641745
10.

Measuring aortic pulse wave velocity using high-field cardiovascular magnetic resonance: comparison of techniques.

Ibrahim el-SH, Johnson KR, Miller AB, Shaffer JM, White RD.

J Cardiovasc Magn Reson. 2010 May 11;12:26. doi: 10.1186/1532-429X-12-26.

11.

Bimolecular fluorescence complementation demonstrates that the c-Fes protein-tyrosine kinase forms constitutive oligomers in living cells.

Shaffer JM, Hellwig S, Smithgall TE.

Biochemistry. 2009 Jun 9;48(22):4780-8. doi: 10.1021/bi900238f.

12.

Promoter methylation blocks FES protein-tyrosine kinase gene expression in colorectal cancer.

Shaffer JM, Smithgall TE.

Genes Chromosomes Cancer. 2009 Mar;48(3):272-84. doi: 10.1002/gcc.20638.

13.

Abnormal regulatory and effector T cell function predispose to autoimmunity following xenogeneic thymic transplantation.

Fudaba Y, Onoe T, Chittenden M, Shimizu A, Shaffer JM, Bronson R, Sykes M.

J Immunol. 2008 Dec 1;181(11):7649-59.

14.
15.

An activity-based two-hybrid system for the selective identification of substrates of protein kinases.

Shaffer JM, Karandikar UC, Bidwai AP.

Anal Biochem. 2006 Aug 1;355(1):154-6. Epub 2006 May 5. No abstract available.

PMID:
16712765
16.

The flanking region sequences of the 15-kDa lipoprotein gene differentiate pathogenic treponemes.

Centurion-Lara A, Castro C, Castillo R, Shaffer JM, Van Voorhis WC, Lukehart SA.

J Infect Dis. 1998 Apr;177(4):1036-40.

PMID:
9534979
17.

Identification of the Treponema pallidum subsp. pallidum glycerophosphodiester phosphodiesterase homologue.

Stebeck CE, Shaffer JM, Arroll TW, Lukehart SA, Van Voorhis WC.

FEMS Microbiol Lett. 1997 Sep 15;154(2):303-10.

18.

Detection of Treponema pallidum by a sensitive reverse transcriptase PCR.

Centurion-Lara A, Castro C, Shaffer JM, Van Voorhis WC, Marra CM, Lukehart SA.

J Clin Microbiol. 1997 Jun;35(6):1348-52.

19.

Conservation of the 15-kilodalton lipoprotein among Treponema pallidum subspecies and strains and other pathogenic treponemes: genetic and antigenic analyses.

Centurion-Lara A, Arroll T, Castillo R, Shaffer JM, Castro C, Van Voorhis WC, Lukehart SA.

Infect Immun. 1997 Apr;65(4):1440-4.

20.

VDRL antibodies enhance phagocytosis of Treponema pallidum by macrophages.

Baker-Zander SA, Shaffer JM, Lukehart SA.

J Infect Dis. 1993 May;167(5):1100-5.

PMID:
8486943
21.
22.
23.

A subpopulation of Treponema pallidum is resistant to phagocytosis: possible mechanism of persistence.

Lukehart SA, Shaffer JM, Baker-Zander SA.

J Infect Dis. 1992 Dec;166(6):1449-53.

PMID:
1431264
24.

Hemangioma of the liver; report of a case with resection of the left hepatic lobe.

FINLEY RK Jr, SHEPARD N, SHAFFER JM.

AMA Arch Surg. 1957 Apr;74(4):543-6. No abstract available.

PMID:
13410328
25.

Evaluation of prolonged antibiotic therapy in mice with chronic Brucella infection due to Brucella melitensis.

SHAFFER JM, KUCERA CJ, SPINK WW.

J Immunol. 1953 Jan;70(1):31-8. No abstract available.

PMID:
13035086
26.
27.

The effect of ACTH and cortisone on the concentration of circulating diphtheria antitoxin.

HAVENS WP Jr, SHAFFER JM, HOPKE CJ Jr.

J Immunol. 1952 Apr;68(4):389-400. No abstract available.

PMID:
14946378
28.

The production of antibody by patients with chronic hepatic disease.

HAVENS WP Jr, SHAFFER JM, HOPKE CJ Jr.

J Immunol. 1951 Oct;67(4):347-56. No abstract available.

PMID:
14888899
29.

Experimental production of diffuse proliferative glomerulonephritis utilizing arteriovenous fistula stress with bacteremia.

LILLEHEI CW, BOBB JR, WARGO D, VISSCHER MB, SHAFFER JM, BELL ET.

Circulation. 1951 Oct;4(4):587-603. No abstract available.

PMID:
14870272
30.

Role of cardiovascular stress in the pathogenesis of endocarditis and glomerulonephritis; observations including method of experimental production utilizing arteriovenous fistulas.

LILLEHEI CW, SHAFFER JM, SPINK WW, BOBB JR, WARGO JD, VISSCHER MB.

AMA Arch Surg. 1951 Oct;63(4):421-34. No abstract available.

PMID:
14868196
31.

Conversion of acetylsulfonamides to the unconjugated form by the chicken kidney.

SHAFFER JM, BIETER RN.

J Pharmacol Exp Ther. 1950 Oct;100(2):192-200. No abstract available.

PMID:
14784955
32.

Studies on the use of aureomycin in hepatic disease. IV. Aureomycin therapy in chronic liver disease; with a note on dermal sensitivity.

SHAFFER JM, BLUEMLE LW Jr, SBOROV VM, NEEFE JR.

Am J Med Sci. 1950 Aug;220(2):173-82. No abstract available.

PMID:
15432453
33.

Studies on the use of aureomycin in hepatic disease. I. Aureomycin therapy in acute viral hepatitis.

SHAFFER JM, FARQUHAR JD, STOKES J Jr, SBOROV VM.

Am J Med Sci. 1950 Jul;220(1):1-5. No abstract available.

PMID:
15425508
34.

Delayed Suture of Sensory Nerves of the Hand.

Shaffer JM, Cleveland F.

Ann Surg. 1950 Apr;131(4):556-63. No abstract available.

35.
36.

Therapy of experimental brucella infection in the developing chick embryo, infection and therapy via the yolk sac.

SHAFFER JM, SPINK WW.

J Immunol. 1948 Aug;59(4):393-403. No abstract available.

PMID:
18875387
37.

Supplemental Content

Loading ...
Support Center